From: Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study
Cancer-specific survival | Univariate analysis HR (95% CI) | Multivariate analysis HR (95% CI) |
---|---|---|
Statin use | ||
ââFormer/neverâ | Ref 1.0 | Ref 1.0 |
ââRecentâ | 1.39 (0.89â2.16) | 1.12 (0.64â1.96) |
Age | ||
â<â70 | Ref 1.0 | Ref 1.0 |
â70â80 | 1.79 (1.04â3.07) | 1.89 (1.09â3.27) |
â>â80 | 2.76 (1.61â4.75 | 2.67 (1.49â4.76) |
Gender | ||
âMale | Ref 1.0 | Â |
âFemale | 1.11 (0.72â1.72) | Â |
Diagnosis | ||
âColon | Ref 1.0 | Â |
âRectum | 0.78 (0.49â1.24) | Â |
Diabetes | ||
âNo | Ref 1.0 | Â |
âYes | 1.56 (0.95â2.55) | Â |
Previous cancer diagnosis | ||
âNo | Ref 1.0 | Â |
âYes | 1.24 (0.66â2.34) | Â |
Stage | ||
âIâ+âII | 0.31 (0.14â0.68) | 0.33 (0.15â0.73) |
âIII | Ref 1.0 | Ref 1.0 |
âIV | 7.63 (4.47â13.0) | 8.70 (8.70â15.1) |
BMI | ||
â<â24.9 | Ref 1.0 | Â |
â25â29.9 | 0.69 (0.42â1.15) | Â |
â>â30 | 0.91 (0.52â1.59) | Â |
NSAID use | ||
âFormer and never | Ref 1.0 | Â |
âRecent | 0.57 (0.28â1.14) | Â |
Salicylic acid use | ||
âFormer and never | Ref 1.0 | Ref 1.0 |
âRecent | 1.67 (1.04â2.68) | 1.39 (0.75â2.60) |